Orchid Cellmark Sees 6 Percent Q4 Revenue Increase

Revenue increase in the quarter was driven by strong growth in its UK business, which offset softness in the US.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories